UnitedHealth Group (NYSE:UNH) Trading Up 0.6% – Should You Buy?

UnitedHealth Group Incorporated (NYSE:UNHGet Free Report) was up 0.6% on Monday . The company traded as high as $517.62 and last traded at $515.84. Approximately 1,167,571 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 2,766,578 shares. The stock had previously closed at $513.00.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. Oppenheimer increased their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Barclays upped their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 27th. Stephens increased their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. KeyCorp started coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. Finally, Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $627.58.

View Our Latest Stock Analysis on UNH

UnitedHealth Group Stock Performance

The stock has a 50-day moving average price of $557.79 and a 200 day moving average price of $561.72. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company has a market cap of $482.36 billion, a price-to-earnings ratio of 34.15, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the business posted $6.56 earnings per share. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds have recently modified their holdings of the stock. M&T Bank Corp grew its stake in UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares in the last quarter. Benjamin Edwards Inc. raised its position in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after acquiring an additional 41,308 shares in the last quarter. Parsifal Capital Management LP bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $21,165,000. Discipline Wealth Solutions LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $558,000. Finally, Franklin Resources Inc. increased its position in UnitedHealth Group by 2.5% during the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after buying an additional 193,800 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.